The interaction of TRPV4 and CaMKII has a major role in cardiac hypertrophy, due to activation of TRPV4 leading to upregulation of Ca2+/CaMKII mediated activation of the NFkB-NLRP3 pathway [111]. The gene discussed is CAMK2G; the disease is cardiac hypertrophy.